Bale, Bradley Field, Doneen, Amy Lynn, Leimgruber, Pierre P, Vigerust, David John. (2022) Atherosclerosis and Vascular Medicine: The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress. Frontiers in Cardiovascular Medicine. November 09, 2022 – LINK
Doneen, Amy Lynn, Bale, Bradley Field, Vigerust, David John (2020) Cardiovascular Prevention: Migrating from a Binary to a Ternary Classification. Frontiers in Cardiovascular Medicine. May 22 2020
Cheng, H.G., B.S. Patel, S.S. Martin, M. Blaha, A. Doneen, B.Bale and S.R. Jones (2016). Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community based prevention clinic. Archives of Medical Science 12(4):728-735.
Feng, D., Esperat, M. C., Doneen, A. L., Bale, B., Song, H., & Green, A. E. (2015). Eight-year outcomes of a program for early prevention of cardiovascular events: a growth-curve analysis. J Cardiovasc Nurs, 30(4), 281-291.
Bale, B. F., Doneen, A.L., Drueding, R., &Charland, S.L. (2006). Aggressive risk factor modification in patients with sub-clinical atherosclerosis reduces plaque burden and regresses carotid artery wall thickness. Atherosclerosis, 7(3), 161.
Doneen, A. L., Bale, B. F., Charland, S. L., & Smith, T.F. (2006). Carotid Intima-media thickness testing identifies at risk patients missed by Framingham 10-year risk scoring. Atherosclerosis, 7(3), 324.
Books
2022
Bradley Bale, MD, Amy Doneen, DNP, Lisa Collier Cool (2022) “Healthy Heart, Healthy Brain” Little, Brown Spark
2014
Bradley Bale, MD, Amy Doneen, ARNP, Lisa Collier Cool (2014) “Beat the Heart Attack Gene” Turner Publishing
Additional Publications by Date
2024
Mewborn, E. K., Tolley, E. A., Wright, D. B., Doneen, A. L., Harvey, M., & Stanfill, A. G. (2024). Haptoglobin genotype is a risk factor for coronary artery disease in prediabetes: A case-control study. American Journal of Preventive Cardiology, 17, Article 100625
Mewborn, E. K., Tolley, E. A., Wright, D. B., Doneen, A. L., Harvey, M., & Stanfill, A. G. (2024). Haptoglobin genotype is a risk factor for coronary artery disease in prediabetes: A case-control study. American Journal of Preventive Cardiology, 17, Article 100625
Miller, C. S., Kryscio, R. J., Doneen, A. L., & Bale, B. F. (2023). Myeloperoxidase: A circulating marker of inflammation and tooth infection. The American Journal of Medicine, 136(4)
2022
Bale, Bradley Field, Doneen, Amy Lynn, Leimgruber, Pierre P, Vigerust, David John. (2022) Atherosclerosis and Vascular Medicine: The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress. Frontiers in Cardiovascular Medicine. November 09, 2022 –LINK
2020
Doneen, Amy Lynn, Bale, Bradley Field, Vigerust, David John (2020) Microvascular disease confers additional risk to COVID-19 infection. Medical Hypotheses. June 15 2020
Doneen, Amy Lynn, Bale, Bradley Field, Vigerust, David John (2020) Cardiovascular Prevention: Migrating from a Binary to a Ternary Classification. Frontiers in Cardiovascular Medicine. May 22 2020
2018
Bale, B.F., Doneen A.D., Vigerust, D.J. (2018) Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping. Frontiers of Cardiovascular Medicine October 16, 2018
Amy L. Doneen& Bradley F. Bale (2018) The BaleDoneen Method (BDM):A disease-inflammation approach to achieve arterial wellness, CRANIO®, 36:4, 209-210, DOI:10.1080/08869634.2018.1479491
2015
Feng, D., Esperat, M. C., Doneen, A. L., Bale, B., Song, H., & Green, A. E. (2015). Eight-year outcomes of a program for early prevention of cardiovascular events: a growth-curve analysis. J Cardiovasc Nurs, 30(4), 281-291.
2014
Doneen, A.L., Dupler, A., &Crogan, A. Why the RDH is a critical member of the health-care team. Registered Dental Hygiene Program. February 2014
Doneen, A.L. The direct program: A disease/inflammatory vs risk factor evaluation cardiovascular testing program. The International Journal of Nursing & Clinical Practices. December 24, 2014.
Doneen, A.L., Dupler, A., &Crogan, N. Cardiovascular wellness and optimal oral health: A symbiotic relationship. Heart Health. November 26, 2014.
Bale, B., Doneen. A. A guarantee of arterial wellness; new era of cardiovascular medicine. Clinical & Experimental Cardiology. 2014. Bale BF, Doneen AL (2014) A Guarantee of Arterial Wellness: New Era of Cardiovascular Medicine. J Clin Exp Cardiolog 5:298.
2013
Doneen, A. L., & Bale, B.F. (2013). Carotid intima-media thickness testing as an asymptomatic cardiovascular disease identifier and method for making therapeutic decisions. Postgraduate Medicine, 125(2),108–23. 2013 doi:10.3810/pgm.2013.03.2645.
Doneen, A. L., & Bale, B. F. (2013). Autophagy, senescence, and arterial inflammation: relationship to arterial health and longevity. Alternative Therapies in Health and Medicine, 19(4), 8–10.
2012
Mason, C. M., & Doneen, A. L. (2012). Niacin—A critical component to the management of atherosclerosis: contemporary management of dyslipidemia to prevent, reduce, or reverse atherosclerotic cardiovascular disease. Journal of Cardiovascular Nursing, 27(4), 303–316. doi:10.1097/JCN.0b013e31821bf93f
Nabors, T., Bale, B., & Doneen, A. (2012). Inculpatory evidence: periodontal disease assessment and treatment is an essential element in cardiovascular wellness programs. Dental Economics, 102(9), 99.
2011
Jones, P. H., Bale, B., & Doneen, A. (2011). Clinician perspective on the benefits of niacin therapy for the treatment of dyslipidemia and strategies to improve long-term adherence to therapy. The Medical Roundtable—Cardiovascular Edition, 2(4): 249–55.
Taylor, A. J., Olendorf, M. W., DeMichele, M., Doneen, A. L., Faulkner, D. A., Sutton-Tyrell, K. (2011). Appropriate use criteria for carotid intima media thickness testing.
2010
Society of Atherosclerosis Imaging and Prevention, developed in collaboration with the International Atherosclerosis Society. Atherosclerosis, 214(1): 43–46. doi:10.1016/j.atherosclerosis.2010.10.045
“Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice.” Bale, B. F., Cobble, M. Postgraduate Medicine.January 2010. 122(1): 7-15.
“Optimizing Hypertension Management in Underserved Rural Populations.” Bale, B. F. Journal of National Medical Association. Jan. 2010. 102 (1): 10-17.
2009
Bale, B., Doneen, A., & Wegner, M. (2009). The identification of occult cardiovascular disease through the use of a novel biomarker: a case report. Journal of Clinical Lipidology, 3(5), 351–54. doi:10.1016/j.jacl.2009.08.004
“Reduce Your Risk of ‘Secret’ Strokes!” Bale, B. F. Women’s World, Oct. 5, 2009, p. 15.
“Markers of Arterial Inflammation.” August 31, 2009, Bale, B. F. Physician’s Weekly, Vol. XXVI Issue No. 33.
“Arterial Inflammation Biomarkers,” [Cover story], Bale, B. F. ADVANCE for Administrators of the Laboratory, July 2009.
2006
Bale, B. F., Doneen, A.L., Drueding, R., &Charland, S.L. (2006). Aggressive risk factor modification in patients with sub-clinical atherosclerosis reduces plaque burden and regresses carotid artery wall thickness. Atherosclerosis, 7(3), 161.
Doneen, A. L., Bale, B. F., Charland, S. L., & Smith, T.F. (2006). Carotid intima-media thickness testing identifies at risk patients missed by Framingham 10-year risk scoring. Atherosclerosis, 7(3), 324.
